KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $1.0 billion.

  • Exact Sciences' Cash & Current Investments fell 176.63% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 176.63%. This contributed to the annual value of $1.0 billion for FY2024, which is 3348.34% up from last year.
  • According to the latest figures from Q3 2025, Exact Sciences' Cash & Current Investments is $1.0 billion, which was down 176.63% from $858.4 million recorded in Q2 2025.
  • Over the past 5 years, Exact Sciences' Cash & Current Investments peaked at $1.4 billion during Q1 2021, and registered a low of $632.1 million during Q4 2022.
  • In the last 5 years, Exact Sciences' Cash & Current Investments had a median value of $817.0 million in 2022 and averaged $898.6 million.
  • As far as peak fluctuations go, Exact Sciences' Cash & Current Investments plummeted by 4508.56% in 2022, and later skyrocketed by 3904.18% in 2024.
  • Over the past 5 years, Exact Sciences' Cash & Current Investments (Quarter) stood at $1.0 billion in 2021, then tumbled by 38.66% to $632.1 million in 2022, then rose by 23.03% to $777.6 million in 2023, then surged by 33.48% to $1.0 billion in 2024, then fell by 3.37% to $1.0 billion in 2025.
  • Its Cash & Current Investments stands at $1.0 billion for Q3 2025, versus $858.4 million for Q2 2025 and $786.2 million for Q1 2025.